Crossmark

Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting

Crossref DOI link: https://doi.org/10.1007/s10620-018-5319-6

Published Online: 2018-10-11

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Checkley, L. Allyson https://orcid.org/0000-0002-3764-9693
Kristofek, Loretta

Kile, Samantha

Bolgar, William
License Information

Text and Data Mining valid from 2018-10-11
More Information

Article History

Received: 29 January 2018

Accepted: 3 October 2018

First Online: 11 October 2018

Compliance with ethical standards

:

: L. Allyson Checkley, Loretta Kristofek, Samantha Kile, and William Bolgar are employees of Coram CVS Specialty Infusion Services.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.